Delivery Order 36F79722D0165-36C24526N0202
Award Date 12/31/25
Potential Completion Date 1/2/26
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Ardelyx, Inc., a pharmaceutical company based in Fremont, California, was awarded a delivery order for XPHOZAH 30 mg by Veterans Integrated Service Network 5 (VISN 5), a component of the Department of Veterans Affairs. This contract, valued at $2,016.52, represents a firm fixed-price delivery order issued on September 19, 2025, with an ultimate completion date of September 23, 2025. The award is performed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and will be...
- This is a federal contract award to Ardelyx, Inc., a for-profit pharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract is a Firm Fixed Price Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with a ceiling value of $2,016.52 and an ultimate completion date of October 24, 2025. The contract is for the delivery of XPHOZAH (tenapanor), a medication developed by Ardelyx to treat hyperphosphatemia in patients on dialysis. This...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Ardelyx, Inc., a for-profit pharmaceutical company, to provide the drug XPHOZAH [TENAPANOR] for the Boro VAMC Pharmacy. The contract, valued at $6,048.81, was issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and has a completion date of April 2024. This delivery order was not set aside for any specific socioeconomic category. Ardelyx currently holds...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Ardelyx, Inc., a for-profit pharmaceutical company, to provide the drug XPHOZAH [TENAPANOR] to the Boro VAMC Pharmacy. The $6,048.81 contract, awarded in April 2024, has a completion date of May 2024. The order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and was not set aside for any socioeconomic category. Ardelyx currently holds two active...
- This is a firm-fixed-price delivery order awarded to Ardelyx, Inc., a for-profit pharmaceutical company, by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract, valued at $16,133.49, is for the delivery of XPHOZAH (tenapanor), a medication used to treat hyperphosphatemia in patients on dialysis. The contract is part of a larger Blanket Purchase Agreement (BPA) valued at $32,500,000, which allows VA medical centers...
- This federal contract award, valued at $45,829.15, was issued by the Department of Veterans Affairs (VA) to Ferring Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The award is a delivery order against Ferring's multiple-award indefinite-delivery vehicle (IDV) on the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), valued at $98.2 million over five years. Through this contract, Ferring will provide the VA with Adstiladrin (nadofaragene firadenovec), a...
- Otsuka America Pharmaceutical Inc. received a delivery order valued at $282,855.34 from the Department of Veterans Affairs' Veterans Integrated Service Network 22 for Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. Issued on July 1, 2022, with a completion date of June 30, 2023, this firm fixed-price delivery order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carried no...
- Otsuka America Pharmaceutical Inc., a specialty pharmaceutical manufacturer headquartered in Rockville, Maryland, received a delivery order award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 on March 8, 2023, for the supply of Jynarque (tolvaptan) 60mg/30mg. This firm-fixed-price contract, valued at $12,195.72, carries an ultimate completion date of March 10, 2023, and is issued for delivery to Pittsburgh, Pennsylvania. The award is issued under the VA's...
- Otsuka America Pharmaceutical Inc., a Maryland-based specialty pharmaceutical manufacturer, was awarded a firm fixed price delivery order valued at $12,195.72 by Veterans Integrated Service Network 5 (VISN 5) on October 4, 2023, with an ultimate completion date of October 6, 2023. The contract calls for the delivery of Jynarque (tolvaptan) in 90mg/30mg dosages to support the Department of Veterans Affairs' healthcare operations in Pittsburgh, Pennsylvania. This delivery order operates under...
- This is a firm fixed-price delivery order award to Travere Therapeutics, Inc., a biopharmaceutical company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21. The contract is for the supply of Travere's specialty pharmaceutical product Filspari 400mg, which is used to treat rare diseases affecting kidney and liver function. The award has a ceiling value of $7,354.26 and a period of performance through September 30, 2024. Travere Therapeutics holds a Federal Supply...